CHRISTINA O'LEARY-PECK: Open Payments
NPI 1396523312 · DURHAM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$252 in 15 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $82 · 2025 $252
Food & beverage: $252
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $81 |
| Otsuka America Pharmaceutical, Inc. | 3 | $51 |
| Alkermes, Inc. | 2 | $39 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $35 |
| Vanda Pharmaceuticals Inc. | 1 | $17 |
| Collegium Pharmaceutical, Inc. | 1 | $15 |
| Tris Pharma Inc | 1 | $14 |
Products named: VRAYLAR, REXULTI, ARISTADA, TRINTELLIX, HETLIOZ, Jornay PM, Dyanavel XR.
Industry payments across NC — which companies pay providers there.
